New tools are needed for next-gen gene therapies
BOSTON - Delivering next-generation viral vectors for use in gene therapies requires that scientists reenvision the tools and process modalities that could be leveraged to make gene therapy a reality, according to Stefano Menegatti, PhD, associate professor at North Carolina State University. Menegatti spoke with ScienceBoard.net during the BioProcess International conference in Boston. Read More
Biotech Week Boston highlights research progress in cell and gene therapy
At Biotech Week Boston, ScienceBoard.net Editor-in-Chief Samantha Black, PhD, spoke with experts in cell and gene therapy technologies. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
